Cargando…

Gliotoxin-mediated bacterial growth inhibition is caused by specific metal ion depletion

Overcoming antimicrobial resistance represents a formidable challenge and investigating bacterial growth inhibition by fungal metabolites may yield new strategies. Although the fungal non-ribosomal peptide gliotoxin (GT) is known to exhibit antibacterial activity, the mechanism(s) of action are unkn...

Descripción completa

Detalles Bibliográficos
Autores principales: Downes, Shane G., Owens, Rebecca A., Walshe, Kieran, Fitzpatrick, David A., Dorey, Amber, Jones, Gary W., Doyle, Sean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533825/
https://www.ncbi.nlm.nih.gov/pubmed/37758814
http://dx.doi.org/10.1038/s41598-023-43300-w
_version_ 1785112257351385088
author Downes, Shane G.
Owens, Rebecca A.
Walshe, Kieran
Fitzpatrick, David A.
Dorey, Amber
Jones, Gary W.
Doyle, Sean
author_facet Downes, Shane G.
Owens, Rebecca A.
Walshe, Kieran
Fitzpatrick, David A.
Dorey, Amber
Jones, Gary W.
Doyle, Sean
author_sort Downes, Shane G.
collection PubMed
description Overcoming antimicrobial resistance represents a formidable challenge and investigating bacterial growth inhibition by fungal metabolites may yield new strategies. Although the fungal non-ribosomal peptide gliotoxin (GT) is known to exhibit antibacterial activity, the mechanism(s) of action are unknown, although reduced gliotoxin (dithiol gliotoxin; DTG) is a zinc chelator. Furthermore, it has been demonstrated that GT synergises with vancomycin to inhibit growth of Staphylococcus aureus. Here we demonstrate, without precedent, that GT-mediated growth inhibition of both Gram positive and negative bacterial species is reversed by Zn(2+) or Cu(2+) addition. Both GT, and the known zinc chelator TPEN, mediate growth inhibition of Enterococcus faecalis which is reversed by zinc addition. Moreover, zinc also reverses the synergistic growth inhibition of E. faecalis observed in the presence of both GT and vancomycin (4 µg/ml). As well as zinc chelation, DTG also appears to chelate Cu(2+), but not Mn(2+) using a 4-(2-pyridylazo)resorcinol assay system and Zn(2+) as a positive control. DTG also specifically reacts in Fe(3+)-containing Siderotec™ assays, most likely by Fe(3+) chelation from test reagents. GSH or DTT show no activity in these assays. Confirmatory high resolution mass spectrometry, in negative ion mode, confirmed, for the first time, the presence of both Cu[DTG] and Fe[DTG](2) chelates. Label free quantitative proteomic analysis further revealed major intracellular proteomic remodelling within E. faecalis in response to GT exposure for 30–180 min. Globally, 4.2–7.2% of detectable proteins exhibited evidence of either unique presence/increased abundance or unique absence/decreased abundance (n = 994–1160 total proteins detected), which is the first demonstration that GT affects the bacterial proteome in general, and E. faecalis, specifically. Unique detection of components of the AdcABC and AdcA-II zinc uptake systems was observed, along with apparent ribosomal reprofiling to zinc-free paralogs in the presence of GT. Overall, we hypothesise that GT-mediated bacterial growth inhibition appears to involve intracellular zinc depletion or reduced bioavailability, and based on in vitro chelate formation, may also involve dysregulation of Cu(2+) homeostasis.
format Online
Article
Text
id pubmed-10533825
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-105338252023-09-29 Gliotoxin-mediated bacterial growth inhibition is caused by specific metal ion depletion Downes, Shane G. Owens, Rebecca A. Walshe, Kieran Fitzpatrick, David A. Dorey, Amber Jones, Gary W. Doyle, Sean Sci Rep Article Overcoming antimicrobial resistance represents a formidable challenge and investigating bacterial growth inhibition by fungal metabolites may yield new strategies. Although the fungal non-ribosomal peptide gliotoxin (GT) is known to exhibit antibacterial activity, the mechanism(s) of action are unknown, although reduced gliotoxin (dithiol gliotoxin; DTG) is a zinc chelator. Furthermore, it has been demonstrated that GT synergises with vancomycin to inhibit growth of Staphylococcus aureus. Here we demonstrate, without precedent, that GT-mediated growth inhibition of both Gram positive and negative bacterial species is reversed by Zn(2+) or Cu(2+) addition. Both GT, and the known zinc chelator TPEN, mediate growth inhibition of Enterococcus faecalis which is reversed by zinc addition. Moreover, zinc also reverses the synergistic growth inhibition of E. faecalis observed in the presence of both GT and vancomycin (4 µg/ml). As well as zinc chelation, DTG also appears to chelate Cu(2+), but not Mn(2+) using a 4-(2-pyridylazo)resorcinol assay system and Zn(2+) as a positive control. DTG also specifically reacts in Fe(3+)-containing Siderotec™ assays, most likely by Fe(3+) chelation from test reagents. GSH or DTT show no activity in these assays. Confirmatory high resolution mass spectrometry, in negative ion mode, confirmed, for the first time, the presence of both Cu[DTG] and Fe[DTG](2) chelates. Label free quantitative proteomic analysis further revealed major intracellular proteomic remodelling within E. faecalis in response to GT exposure for 30–180 min. Globally, 4.2–7.2% of detectable proteins exhibited evidence of either unique presence/increased abundance or unique absence/decreased abundance (n = 994–1160 total proteins detected), which is the first demonstration that GT affects the bacterial proteome in general, and E. faecalis, specifically. Unique detection of components of the AdcABC and AdcA-II zinc uptake systems was observed, along with apparent ribosomal reprofiling to zinc-free paralogs in the presence of GT. Overall, we hypothesise that GT-mediated bacterial growth inhibition appears to involve intracellular zinc depletion or reduced bioavailability, and based on in vitro chelate formation, may also involve dysregulation of Cu(2+) homeostasis. Nature Publishing Group UK 2023-09-27 /pmc/articles/PMC10533825/ /pubmed/37758814 http://dx.doi.org/10.1038/s41598-023-43300-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Downes, Shane G.
Owens, Rebecca A.
Walshe, Kieran
Fitzpatrick, David A.
Dorey, Amber
Jones, Gary W.
Doyle, Sean
Gliotoxin-mediated bacterial growth inhibition is caused by specific metal ion depletion
title Gliotoxin-mediated bacterial growth inhibition is caused by specific metal ion depletion
title_full Gliotoxin-mediated bacterial growth inhibition is caused by specific metal ion depletion
title_fullStr Gliotoxin-mediated bacterial growth inhibition is caused by specific metal ion depletion
title_full_unstemmed Gliotoxin-mediated bacterial growth inhibition is caused by specific metal ion depletion
title_short Gliotoxin-mediated bacterial growth inhibition is caused by specific metal ion depletion
title_sort gliotoxin-mediated bacterial growth inhibition is caused by specific metal ion depletion
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533825/
https://www.ncbi.nlm.nih.gov/pubmed/37758814
http://dx.doi.org/10.1038/s41598-023-43300-w
work_keys_str_mv AT downesshaneg gliotoxinmediatedbacterialgrowthinhibitioniscausedbyspecificmetaliondepletion
AT owensrebeccaa gliotoxinmediatedbacterialgrowthinhibitioniscausedbyspecificmetaliondepletion
AT walshekieran gliotoxinmediatedbacterialgrowthinhibitioniscausedbyspecificmetaliondepletion
AT fitzpatrickdavida gliotoxinmediatedbacterialgrowthinhibitioniscausedbyspecificmetaliondepletion
AT doreyamber gliotoxinmediatedbacterialgrowthinhibitioniscausedbyspecificmetaliondepletion
AT jonesgaryw gliotoxinmediatedbacterialgrowthinhibitioniscausedbyspecificmetaliondepletion
AT doylesean gliotoxinmediatedbacterialgrowthinhibitioniscausedbyspecificmetaliondepletion